Related Experiment Video
Updated: Dec 14, 2025
Oral Biofilm Formation on Different Materials for Dental Implants
Published on: June 24, 2018
Influence of antihypertensive medications on the clinical parameters of anodized dental implants: a retrospective
Keisuke Seki1,2, Akira Hasuike3,4, Yoshihiro Iwano5
1Implant Dentistry, Nihon University School of Dentistry Dental Hospital, Tokyo, Japan. seki.keisuke@nihon-u.ac.jp.
Background:
Hypertension is a chronic medical condition in which blood pressure in the arteries is elevated. Given the large proportion of dental implant patients using antihypertensive medications, it is crucial to evaluate the effects of these drugs on the clinical parameters of osseointegrated implants. The aim of the present retrospective cohort study was to evaluate the influence of antihypertensive medications on clinical peri-implant tissue parameters.
Methods:
Thirty-five patients received a total of 77 anodized dental implants. Based on the history of the use of antihypertensive medications, the patients were divided into two groups: the group taking antihypertensive medications (AH group) and the group of healthy patients (H group). Implants were followed up clinically and radiologically, with a focus on the peri-implant soft tissue parameters probing pocket depth, bleeding on probing, modified plaque index, and marginal peri-implant bone level stability.
Results:
None of the implants were lost, and no technical failures occurred. The mean follow-up duration was 7 years and 1 month. A significant difference was observed in the probing pocket depth 3.8 ± 1.3 mm in the AH group and 3.0 ± 0.7 mm in the H group. In the AH and H groups, 26.5% (9/34) and 4.7% (2/43) of the patients were diagnosed with peri-implantitis at the implant level, respectively.
Conclusions:
Our findings suggest some correlations between antihypertensive medication use and clinical parameters in anodized peri-implant tissue.
